Combination of gaba agonists and aldose reductase inhibitors
CA 2430309 A1 · Owner: Pfizer Products Inc. · Inventors: Mylari, Banavara Lakshman
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to pharmaceutical compositions comprising combinations of a GABA agonist, a prodrug thereof or a pharmaceutically acceptable salt of said GABA agonist or said prodrug and an ARI a prodrug thereof or a , pharmaceutically acceptable salt of said ARI or said prodrug kits containing , such combinations and methods of using such combinations to treat mammals including humans, suffering from diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy diabetic , retinopathy, diabetic microangiopathy diabetic macroangiopathy, cataracts or foot ulcers.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.